September 2026
| L | M | X | J | V | S | D |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 |
| Publication | |
|---|---|
| Title: | DAIDZEIN AND EQUOL: EX VIVO AND IN SILICO APPROACHES TARGETING COX-2, INOS, AND THE CANONICAL INFLAMMASOME SIGNALING PATHWAY |
| Journal title: | PHARMACEUTICALS |
| Contribution type: | ARTICULO |
| Journal number: | 5 |
| Volume number: | 17 |
| Number of pages of the publication: | 1 - |
| Publication year: | 2024 |
| Authors: |
YAZMÍN K. MÁRQUEZ-FLORES ELIZDATH MARTÍNEZ-GALERO JOSÉ CORREA-BASURTO YUDIBETH SIXTO LÓPEZ MARIA ISABEL VILLEGAS-LAMA MARÍA ROSILLO CATALINA ALARCON DE LA LASTRA-ROMERO |